March 2011 PMID 20974015

Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects.

Michaël Messaoudi, Robert Lalonde, Nicolas Violle, Hervé Javelot, Didier Desor, Amine Nejdi, Jean-François Bisson, Catherine Rougeot, Matthieu Pichelin, Murielle Cazaubiel, Jean-Marc Cazaubiel

Full text PDF Download social card

Mentions

Peak: 2 in Nov 2020

across 6 sources since Aug 2019

Extended reach

36,074

potential audience

Total likes

1,876

Video views

21,410

Mentions per month

Aug 2019 – Sep 2025

Where it's discussed

News34 articles
Facebook17 posts
Blogs8 articles
X / Twitter6 posts
YouTube3 videos
Reddit3 posts

AI synopsis

What people are saying

Discussions show an overall positive view, exemplified by remarks like 'Swallowing bugs (probiotics) for brain health,' which conveys curiosity and somewhat playful tone, as well as personal stories like @hamidr_'s experience with anxiety and gut health. These examples highlight an interest in real-world applications and implications, and the use of casual language and references to gut health contribute to moderate engagement and recognition of potential impact.

AgreementModerate agreement

Most posts acknowledge the potential benefits of the probiotic formulation, with some explicitly supporting its anxiolytic effects, indicating general agreement.

InterestHigh interest

Discussions demonstrate high curiosity about the relationship between gut health and mood, reflecting a strong interest in the study's implications.

EngagementModerate engagement

Some comments delve into personal experiences and related research, showing moderate engagement, though few analyze detailed methodologies or broader impacts.

ImpactModerate impact

While users recognize the significance of the findings for mental health and gut-brain interaction, the overall perceived impact remains cautious, without widespread claims of groundbreaking change.

Abstract in brief

The study tested a probiotic formulation containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175, finding it reduced anxiety-like behavior in rats and psychological stress in healthy humans.
In rats, two weeks of daily probiotic treatment decreased anxiety behaviors, while in humans, 30 days of intake improved measures of anxiety, depression, stress, and coping strategies, along with lower cortisol levels.
Overall, these results suggest that this probiotic combo may have calming effects on both animal models and people, potentially benefiting mood and mental health through gut-brain interactions.]

Read the full abstract